Stepwise or linear decrease in penetrance of type 1 diabetes with lower-risk HLA genotypes over the past 40 years.
about
Type 1 diabetesThe microbiology of human hygiene and its impact on type 1 diabetesAmerican Diabetes Association and JDRF Research Symposium: Diabetes and the MicrobiomeThe incidence of diabetes among 0-34 year olds in Sweden: new data and better methods.The effect of childhood cow's milk intake and HLA-DR genotype on risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young.Temporal trends of HLA, CTLA-4 and PTPN22 genotype frequencies among type 1 diabetes in Continental Italy.Assessing age-related etiologic heterogeneity in the onset of islet autoimmunity.Regulatory vs. inflammatory cytokine T-cell responses to mutated insulin peptides in healthy and type 1 diabetic subjects.Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine.Juvenile Diabetes Research Foundation: mission, strategy, and prioritiesAlterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 DiabetesSeroreactivity against Specific L5P Antigen from Mycobacterium avium subsp. paratuberculosis in Children at Risk for T1D.Innate inflammation in type 1 diabetesThe pathogenesis and natural history of type 1 diabetes.Early-onset, coexisting autoimmunity and decreased HLA-mediated susceptibility are the characteristics of diabetes in Down syndrome.George S. Eisenbarth: insulin and type 1 diabetes.Altered immune regulation in type 1 diabetes.The relationship between BMI and insulin resistance and progression from single to multiple autoantibody positivity and type 1 diabetes among TrialNet Pathway to Prevention participants.Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.Emerging immune therapies in type 1 diabetes and pancreatic islet transplantation.Trials in the prevention of type 1 diabetes: current and futureJDRF's vision and strategy for prevention of type 1 diabetes.Recognition of ZnT8, Proinsulin, and Homologous MAP Peptides in Sardinian Children at Risk of T1D Precedes Detection of Classical Islet Antibodies.Genomic evaluation of HLA-DR3+ haplotypes associated with type 1 diabetes.The proportion of familial cases of type 1 diabetes is increasing simultaneously with the disease incidence: Eighteen years of the Israeli Pediatric Diabetes Registry.The threshold hypothesis: solving the equation of nurture vs nature in type 1 diabetes.Application of a Genetic Risk Score to Racially Diverse Type 1 Diabetes Populations Demonstrates the Need for Diversity in Risk-Modeling.Genetic Risk Scores for Type 1 Diabetes Prediction and Diagnosis
P2860
Q27000491-A2132CAE-ADB8-47AC-94BD-68D89721A6D5Q27026794-8BC62AE8-35FD-46CE-AD52-72319C838DCEQ28602363-7AC2EB6C-D76F-470C-BE6C-94E4E5252AF2Q30795830-A96672EF-1F37-45E4-9F4B-52CF73F579CAQ33923240-780E16B2-8174-450D-97F7-9EE559A30F77Q34684270-B75CC4AE-93C0-4782-B64E-F6AF06F4A150Q35319328-E2295A0D-8D8A-40FF-97F6-4A33A6178091Q35378628-319BD869-6B74-48EC-854D-3298FB2220E8Q35563714-E39BFE19-EE45-4834-9275-830C9B5C88DCQ35612407-8C2CCC3E-EF6F-485A-BAAE-A13A96206FC0Q35661927-D772EA0C-6CF0-4090-8DF8-80B79EEE5DD4Q36060074-46E77736-8CD3-4B33-BCAF-7E92465A027CQ36225939-65968A27-F76E-4E29-A9BA-CC60B500CD11Q36526611-C5A7C051-3369-4D72-A00E-7E8849C410CDQ36782751-B7C5F5B3-BBD0-48D4-A499-861F952A7037Q36868176-2C0BB1C7-45A8-4614-8AD5-AD747577DDBDQ37148578-5C86774F-DC8D-450D-82BF-3DF30839E280Q37368421-8FFCD802-E8E4-4675-B7D1-C7F036471687Q37659402-2B4A13AC-EEAD-4DB7-82A9-5C89D3BF19B3Q38063547-182B408A-594E-4F0C-9A4A-2AD74543A942Q38237031-7601022E-56A1-4264-A66B-05269787FF5FQ38895435-1D502E17-4F39-4074-8E83-4536D403937BQ40813098-BA5933A0-BE6A-4B2E-82F3-179E1ECDBAD3Q43606415-EE507726-5405-4634-8098-25655686BF5AQ47386273-5CE8D528-73E6-463F-BE40-4213FA941DD0Q51546631-3202A0F4-CB6D-491C-8674-8259191BD9A4Q52655332-D0DD2481-B677-4E74-B434-0F8BD9134F0BQ57924676-29432304-C89D-48F9-9810-280AFEDEAFBD
P2860
Stepwise or linear decrease in penetrance of type 1 diabetes with lower-risk HLA genotypes over the past 40 years.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Stepwise or linear decrease in ...... otypes over the past 40 years.
@ast
Stepwise or linear decrease in ...... otypes over the past 40 years.
@en
Stepwise or linear decrease in ...... otypes over the past 40 years.
@nl
type
label
Stepwise or linear decrease in ...... otypes over the past 40 years.
@ast
Stepwise or linear decrease in ...... otypes over the past 40 years.
@en
Stepwise or linear decrease in ...... otypes over the past 40 years.
@nl
prefLabel
Stepwise or linear decrease in ...... otypes over the past 40 years.
@ast
Stepwise or linear decrease in ...... otypes over the past 40 years.
@en
Stepwise or linear decrease in ...... otypes over the past 40 years.
@nl
P2093
P2860
P356
P1433
P1476
Stepwise or linear decrease in ...... otypes over the past 40 years.
@en
P2093
Andrea K Steck
George S Eisenbarth
Sunanda R Babu
Taylor K Armstrong
Type 1 Diabetes Genetics Consortium
P2860
P304
P356
10.2337/DB10-1419
P407
P577
2011-02-09T00:00:00Z